Cost of illness of diabetes mellitus in Indonesia: a systematic review

Abstract

Objectives Diabetes Mellitus (DM) is a group of insulin metabolism disorder that affects the socio-economic conditions of the community. The cost of treating diabetes in 2019 was USD 760 billion and by 2045 there are predicted to be 700 million people living with diabetes. The purpose of this systematic review was to provide an overview of the economic burden caused by Diabetes Mellitus for the government, health care providers, and for the community. Methods This systematic review was carried out by considering the related studies about the cost of illness, evaluation of disease costs, or therapeutic costs for various types of diabetes mellitus that were published in both English and Indonesian. The search engines PUBMED, DOAJ, SCOPUS, SCIENCE DIRECT, and GOOGLE SCHOLAR were used without date published restrictions. Results A systematic search identifies 18 eligible studies conducted in various regions in Indonesia. The study was retrospective with variation in their perspectives and methods to estimate the diabetes cost. Drug cost was the major contributor to direct medical cost followed by complications cost while other cost was affected by transportation cost, productivity losses, and time spent by family accompanying patients. Conclusions Diabetes mellitus creates a significant financial burden and affects the health care system as well as the individual and society as a whole. Research about the cost of diabetes in the future should be carried out on a large scale in order to get a more specific cost estimation.

Pelatihan Senam Kaki Buerger Allen di Puskemas Purwodiningratan

“…Diperkirakan pada tahun 2045, 700 juta orang akan menderita diabetes, menelan biaya 760 juta dollar Amerika Serikat untuk sembuh pada tahun 2019. Diabetes mellitus memiliki dampak ekonomi yang signifikan pada orang dan masyarakat luas, serta sistem perawatan kesehatan 8 . Biaya perawatan kesehatan langsung di Indonesia pada tahun 2016 diperkirakan menggunakan data dari Database Asuransi Kesehatan Nasional Indonesia, atau BPJS, yang mencakup biaya kelompok yang terkait dengan diagnosis serta biaya sendiri untuk pasien yang mendapatkan perawatan yang lebih luas.…”

Cost of Illness Study in Thyroid Patients: A Systematic Review

“…In this study, quality of the research was critically evaluated following previous C.O.I. related research (Patty et al, 2021). This study used a 10-point checklist; it will be given a score of 2 if all criteria were met, a score of 1 if only some criteria were met, and a score of 0 if only a few criteria were met.…”

Inhibition of α-Glucosidase Enzyme by Ethanol Extract of Kratom Leaf Variant (Mitragyna speciosa Korth.)

“…The total cost incurred by JKN (National Health Insurance) amounted to 6.1 trillion for the treatment of diabetes and its complications. The cost needed by patients without complications is 5.4 million/person/year and for the treatment of complications is 14 million/person/year (Patty, Mufarrihah, and Nita 2021). This data shows the urgent need to implement strategies to overcome and reduce mortality from diabetes mellitus.…”